1983
DOI: 10.1203/00006450-198301000-00011
|View full text |Cite
|
Sign up to set email alerts
|

Chemotactic Receptor of Cord Blood Granulocytes to the Synthesized Chemotactic Peptide N-Formyl-Methionyl-Leucyl-Phenylalanine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

1984
1984
2006
2006

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 12 publications
0
10
0
Order By: Relevance
“…The whole blood chemotaxis assay used in this study approximates in vivo conditions more closely than separated cell assays, however, it is less useful for determination of the relative effects of serum and cellular factors on PMN chemotaxis. Previous studies in healthy neonates have identified both humoral (6,8,(21)(22)(23) and cellular (3)(4)(5)(24)(25)(26) abnormalities which could explain decreased PMN chemotaxis in neonates compared with adults. Serum defects have included decreased levels of complement (8,(21)(22) and the presence of a chemotactic factor inactivator (8,23).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The whole blood chemotaxis assay used in this study approximates in vivo conditions more closely than separated cell assays, however, it is less useful for determination of the relative effects of serum and cellular factors on PMN chemotaxis. Previous studies in healthy neonates have identified both humoral (6,8,(21)(22)(23) and cellular (3)(4)(5)(24)(25)(26) abnormalities which could explain decreased PMN chemotaxis in neonates compared with adults. Serum defects have included decreased levels of complement (8,(21)(22) and the presence of a chemotactic factor inactivator (8,23).…”
Section: Discussionmentioning
confidence: 99%
“…Serum defects have included decreased levels of complement (8,(21)(22) and the presence of a chemotactic factor inactivator (8,23). Cellular defects have included decreased membrane receptors for chemoattractants (24), impaired microtubule assembly (25), decreased adherence (3-9, and decreased membrane deformability (26). Decreased PMN chemotaxis in the stressed neonates might have been due to further impairment in any one or more of these defects or might have resulted from other defects such as the presence of a cell directed inhibitor or activated complement fragments.…”
Section: Discussionmentioning
confidence: 99%
“…f. Met-Le~-[~HlPhe (specific activity, 46.4 Ci/mol) was purchased from New England Nuclear Corp., purified on Dowex 50 W X 2 with 0.01 N HCl, stored at 4"C, and used after neutralizing with 0.1 N NaOH as described (17). The 0.05 pCi of labeled peptide M) was incubated with 20 p1 of either the patient's or control's serum at 37°C for 2 h. After incubation the medium was deproteinized with acetone and lyophilized.…”
Section: Methodsmentioning
confidence: 99%
“…In the human neonate, factors suggested to be responsible for the defect include deficiency of membrane receptors, cytoskeletal abnormalities, and membrane rigidity (2)(3)(4)(5)17). We have previously shown that chemotaxis of neutrophils obtained from human cord blood is comparable to adult values and "increased" in comparison to chemotaxis of neutrophils from same infant 48-72 h after birth (18).…”
Section: Neutrophil Chemotaxis Withmentioning
confidence: 99%
“…Defects in phagocyte chemotaxis may be due to membrane defects, reduced number of receptors for the chemotactic agent, or to cytoskeletal abnormalities. The chemotactic defect of human neonatal phagocyte originally described by Miller (1) may be due to deficiencies in any or all these components (2)(3)(4)(5). Ontogeny of some phagocytic functions, but not chemotaxis, has been evaluated in fetal and neonatal animal models (6,7).…”
mentioning
confidence: 99%